Maharashtra, India

Dattatraya Shinde

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 4.9

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2013-2015

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Dattatraya Shinde: Innovator in Pharmaceutical Chemistry

Introduction

Dattatraya Shinde is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds. With a total of four patents to his name, Shinde's work has the potential to impact the medical industry positively.

Latest Patents

Among his latest patents is the invention of an anhydrate of tiotropium bromide. This invention relates to a novel form of anhydrous tiotropium bromide, including processes for its preparation, pharmaceutical compositions comprising this compound, and various uses of these compositions. The focus on anhydrous forms highlights the importance of stability and efficacy in pharmaceutical applications.

Career Highlights

Dattatraya Shinde has worked with Generics UK Limited, where he has contributed to the development of generic pharmaceuticals. His expertise in the field has allowed him to innovate and create formulations that can enhance patient care and treatment options.

Collaborations

Shinde has collaborated with professionals such as Bindu Manojkumar and Dattatrey Kokane. These collaborations have likely enriched his research and development efforts, leading to successful innovations in his field.

Conclusion

Dattatraya Shinde's work in pharmaceutical chemistry exemplifies the spirit of innovation. His patents, particularly in the area of tiotropium bromide, showcase his commitment to advancing medical science. Through his career and collaborations, he continues to contribute to the betterment of healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…